Global Oncolytic Virus Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Oncolytic Virus market size will reach 24.31 Million USD in 2025 and is projected to reach 42.92 Million USD by 2032, with a CAGR of 8.46% (2025-2032). Notably, the China Oncolytic Virus market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
An oncolytic virus is a type of virus that has been engineered or naturally evolved to selectively infect and kill cancer cells while sparing healthy cells. These viruses can efficiently target and replicate within cancer cells, ultimately leading to their destruction. Oncolytic viruses can be derived from various virus families, including adenoviruses, herpesviruses, reoviruses, and others. When used as a therapeutic agent, oncolytic viruses are often modified to enhance their safety, target specificity, and anticancer potency. They can be administered directly into tumor sites, intravenously, or via other routes depending on the specific virus and cancer type being targeted. Once inside the cancer cells, the oncolytic viruses infect and replicate, causing the cancer cells to burst and release viral particles that can further infect neighboring cancer cells. In addition to direct tumor cell lysis, oncolytic viruses can also stimulate the immune system to mount an immune response against the cancer, further aiding in tumor eradication. Oncolytic viruses are being actively researched and developed as a promising therapeutic approach for various types of cancers, either as standalone treatments or in combination with other therapies.
The major global suppliers of Oncolytic Virus include Amgen, Shanghai Sunway Biotech, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Oncolytic Virus. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Oncolytic Virus market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Oncolytic Virus market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Oncolytic Virus industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Oncolytic Virus Include:
Amgen
Shanghai Sunway Biotech
Oncolytic Virus Product Segment Include:
Imlygic
Oncorine
Others
Oncolytic Virus Product Application Include:
Melanoma
Other Cancers
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Oncolytic Virus Industry PESTEL Analysis
Chapter 3: Global Oncolytic Virus Industry Porter's Five Forces Analysis
Chapter 4: Global Oncolytic Virus Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Oncolytic Virus Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Oncolytic Virus Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Oncolytic Virus Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Oncolytic Virus market size will reach 24.31 Million USD in 2025 and is projected to reach 42.92 Million USD by 2032, with a CAGR of 8.46% (2025-2032). Notably, the China Oncolytic Virus market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
An oncolytic virus is a type of virus that has been engineered or naturally evolved to selectively infect and kill cancer cells while sparing healthy cells. These viruses can efficiently target and replicate within cancer cells, ultimately leading to their destruction. Oncolytic viruses can be derived from various virus families, including adenoviruses, herpesviruses, reoviruses, and others. When used as a therapeutic agent, oncolytic viruses are often modified to enhance their safety, target specificity, and anticancer potency. They can be administered directly into tumor sites, intravenously, or via other routes depending on the specific virus and cancer type being targeted. Once inside the cancer cells, the oncolytic viruses infect and replicate, causing the cancer cells to burst and release viral particles that can further infect neighboring cancer cells. In addition to direct tumor cell lysis, oncolytic viruses can also stimulate the immune system to mount an immune response against the cancer, further aiding in tumor eradication. Oncolytic viruses are being actively researched and developed as a promising therapeutic approach for various types of cancers, either as standalone treatments or in combination with other therapies.
The major global suppliers of Oncolytic Virus include Amgen, Shanghai Sunway Biotech, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Oncolytic Virus. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Oncolytic Virus market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Oncolytic Virus market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Oncolytic Virus industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Oncolytic Virus Include:
Amgen
Shanghai Sunway Biotech
Oncolytic Virus Product Segment Include:
Imlygic
Oncorine
Others
Oncolytic Virus Product Application Include:
Melanoma
Other Cancers
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Oncolytic Virus Industry PESTEL Analysis
Chapter 3: Global Oncolytic Virus Industry Porter's Five Forces Analysis
Chapter 4: Global Oncolytic Virus Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Oncolytic Virus Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Oncolytic Virus Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Oncolytic Virus Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Oncolytic Virus Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Oncolytic Virus Product by Type
- 1.2.1 Imlygic
- 1.2.2 Oncorine
- 1.2.3 Others
- 1.3 Oncolytic Virus Product by Application
- 1.3.1 Melanoma
- 1.3.2 Other Cancers
- 1.4 Global Oncolytic Virus Market Size Analysis (2020-2032)
- 1.5 Oncolytic Virus Market Development Status and Trends
- 1.5.1 Oncolytic Virus Industry Development Status Analysis
- 1.5.2 Oncolytic Virus Industry Development Trends Analysis
- 2 Oncolytic Virus Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Oncolytic Virus Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Oncolytic Virus Market Analysis by Country
- 4.1 Global Oncolytic Virus Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Oncolytic Virus Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Oncolytic Virus Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Oncolytic Virus Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Oncolytic Virus Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Oncolytic Virus Market Revenue and Growth Rate (2020-2032)
- 4.5 China Oncolytic Virus Market Revenue and Growth Rate (2020-2032)
- 4.6 France Oncolytic Virus Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Oncolytic Virus Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Oncolytic Virus Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Oncolytic Virus Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Oncolytic Virus Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Oncolytic Virus Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Oncolytic Virus Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Oncolytic Virus Market Revenue and Growth Rate (2020-2032)
- 4.14 India Oncolytic Virus Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Oncolytic Virus Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Oncolytic Virus Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Oncolytic Virus Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Oncolytic Virus Market Revenue by Key Suppliers (2021-2025)
- 5.2 Oncolytic Virus Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Oncolytic Virus Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Oncolytic Virus Market Analysis by Type
- 6.1 Global Oncolytic Virus Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Oncolytic Virus Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Amgen
- 7.1.1 Amgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Amgen Oncolytic Virus Product Portfolio
- 7.1.3 Amgen Oncolytic Virus Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Shanghai Sunway Biotech
- 7.2.1 Shanghai Sunway Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Shanghai Sunway Biotech Oncolytic Virus Product Portfolio
- 7.2.3 Shanghai Sunway Biotech Oncolytic Virus Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Oncolytic Virus Industry Chain Analysis
- 8.2 Oncolytic Virus Product Downstream Application Analysis
- 8.2.1 Global Oncolytic Virus Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Oncolytic Virus Revenue and Forecast by Application (2020-2032)
- 8.3 Oncolytic Virus Typical Downstream Customers
- 8.4 Oncolytic Virus Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
